Joshua Lang1, Ronit Katz2, Joachim H Ix3, Orlando M Gutierrez4, Carmen A Peralta5, Chirag R Parikh6, Suzanne Satterfield7, Snezana Petrovic8, Prasad Devarajan9, Michael Bennett9, Linda F Fried10, Steven R Cummings11, Mark J Sarnak12, Michael G Shlipak13. 1. Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. 2. Kidney Research Institute, University of Washington, Seattle, WA, USA. 3. Division of Nephrology and Hypertension, Department of Medicine, University of California San Diego, San Diego, CA, USA. 4. University of Alabama at Birmingham, Birmingham, AL, USA. 5. Department of Medicine, University of California, San Francisco, CA, USA. 6. Section of Nephrology, Yale University, West Haven, CT, USA. 7. Department of Preventive Medicine, University of Tennessee, Memphis, TN, USA. 8. Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, NC, USA. 9. Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. 10. Veterans Affairs (VA) Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 11. Research Institute, California Pacific Medical Center, San Francisco, CA, USA. 12. Division of Nephrology, Tufts Medical Center, Boston, MA, USA. 13. Division of General Internal Medicine, San Francisco Veterans Affairs Medical Center, and the Departments of Medicine, Epidemiology, and Biostatistics, University of California, San Francisco, CA, USA.
Abstract
Background: Previous studies in HIV-infected individuals have demonstrated serum albumin to be strongly associated with kidney function decline, independent of urine albumin and inflammatory markers. Lower serum albumin concentrations may be an under-appreciated risk factor for kidney function decline in elders. Methods: We performed a cohort analysis in the Health Aging and Body Composition Study, a cohort of well-functioning, bi-racial, community-dwelling elders between the age of 70 and 79 years. We examined the associations of serum albumin concentration with longitudinal kidney function decline by estimated glomerular filtration rate (eGFR). Outcomes included linear eGFR decline, rapid kidney function decline defined as >30% decrease in eGFR, defined as a final eGFR <60 mL/min/1.73 m2 in those with an eGFR >60 mL/min/1.73 m2 at baseline. Cystatin C-based eGFR was calculated at baseline, Year 3 and Year 10. Results: Mean age was 74 years, and mean eGFR was 73 mL/min/1.73 m2 at baseline. The mean rate of eGFR change was 1.81 mL/min/1.73 m2 per year. After multivariate adjustment, lower serum albumin concentrations were strongly and independently associated with kidney function decline (-0.11 mL/min/1.73 m2 per year for each standard deviation decrease serum albumin; -0.01 to - 0.20) with no attenuation after adjustment for urine albumin and inflammatory markers (-0.12, -0.03 to - 0.22). When divided into quartiles, serum albumin levels ≤3.80 g/dL were associated with increased odds of rapid kidney function decline (odds ratio 1.59; 1.12-2.26) and increased risk of incident chronic kidney disease (incident rate ratio 1.29; 1.03-1.62) relative to levels >4.21g/dL. Urine albumin to creatinine ratio (ACR) was also significantly and independently associated with kidney function decline (-0.08 mL/min/1.73 m2 per year for urine ACR >30 mg/g; -0.82 to - 0.13). Conclusions: Lower serum albumin levels are strongly and independently associated with kidney function decline in elders, independent of clinical risk factors, urine albumin and measured inflammatory markers.
Background: Previous studies in HIV-infected individuals have demonstrated serum albumin to be strongly associated with kidney function decline, independent of urine albumin and inflammatory markers. Lower serum albumin concentrations may be an under-appreciated risk factor for kidney function decline in elders. Methods: We performed a cohort analysis in the Health Aging and Body Composition Study, a cohort of well-functioning, bi-racial, community-dwelling elders between the age of 70 and 79 years. We examined the associations of serum albumin concentration with longitudinal kidney function decline by estimated glomerular filtration rate (eGFR). Outcomes included linear eGFR decline, rapid kidney function decline defined as >30% decrease in eGFR, defined as a final eGFR <60 mL/min/1.73 m2 in those with an eGFR >60 mL/min/1.73 m2 at baseline. Cystatin C-based eGFR was calculated at baseline, Year 3 and Year 10. Results: Mean age was 74 years, and mean eGFR was 73 mL/min/1.73 m2 at baseline. The mean rate of eGFR change was 1.81 mL/min/1.73 m2 per year. After multivariate adjustment, lower serum albumin concentrations were strongly and independently associated with kidney function decline (-0.11 mL/min/1.73 m2 per year for each standard deviation decrease serum albumin; -0.01 to - 0.20) with no attenuation after adjustment for urine albumin and inflammatory markers (-0.12, -0.03 to - 0.22). When divided into quartiles, serum albumin levels ≤3.80 g/dL were associated with increased odds of rapid kidney function decline (odds ratio 1.59; 1.12-2.26) and increased risk of incident chronic kidney disease (incident rate ratio 1.29; 1.03-1.62) relative to levels >4.21g/dL. Urine albumin to creatinine ratio (ACR) was also significantly and independently associated with kidney function decline (-0.08 mL/min/1.73 m2 per year for urine ACR >30 mg/g; -0.82 to - 0.13). Conclusions: Lower serum albumin levels are strongly and independently associated with kidney function decline in elders, independent of clinical risk factors, urine albumin and measured inflammatory markers.
Authors: Linda F Fried; Ronit Katz; Mark J Sarnak; Michael G Shlipak; Paulo H M Chaves; Nancy Swords Jenny; Catherine Stehman-Breen; Dan Gillen; Anthony J Bleyer; Calvin Hirsch; David Siscovick; Anne B Newman Journal: J Am Soc Nephrol Date: 2005-10-26 Impact factor: 10.121
Authors: Maneesh Sud; Navdeep Tangri; Adeera Levin; Melania Pintilie; Andrew S Levey; David M Naimark Journal: Am J Kidney Dis Date: 2014-01-28 Impact factor: 8.860
Authors: E M Simonsick; A B Newman; M C Nevitt; S B Kritchevsky; L Ferrucci; J M Guralnik; T Harris Journal: J Gerontol A Biol Sci Med Sci Date: 2001-10 Impact factor: 6.053
Authors: Caroline S Fox; Martin G Larson; Eric P Leip; Bruce Culleton; Peter W F Wilson; Daniel Levy Journal: JAMA Date: 2004-02-18 Impact factor: 56.272
Authors: Matteo Cesari; Brenda W J H Penninx; Anne B Newman; Stephen B Kritchevsky; Barbara J Nicklas; Kim Sutton-Tyrrell; Russell P Tracy; Susan M Rubin; Tamara B Harris; Marco Pahor Journal: Am J Cardiol Date: 2003-09-01 Impact factor: 2.778
Authors: Christopher Keller; Ronit Katz; Mark J Sarnak; Linda F Fried; Bryan Kestenbaum; Mary Cushman; Michael G Shlipak Journal: Nephrol Dial Transplant Date: 2009-09-03 Impact factor: 5.992
Authors: Stuart J Shankland; Yuliang Wang; Andrey S Shaw; Joshua C Vaughan; Jeffrey W Pippin; Oliver Wessely Journal: J Am Soc Nephrol Date: 2021-11 Impact factor: 10.121
Authors: Arwa Nada; David Askenazi; Juan C Kupferman; Maroun Mhanna; John D Mahan; Louis Boohaker; Linzi Li; Russell L Griffin Journal: Pediatr Nephrol Date: 2021-10-18 Impact factor: 3.651
Authors: Ninad S Chaudhary; Hemant K Tiwari; Bertha A Hidalgo; Nita A Limdi; Richard J Reynolds; Mary Cushman; Neil A Zakai; Leslie Lange; Suzanne E Judd; Cheryl A Winkler; Jeffrey B Kopp; Orlando M Gutiérrez; Marguerite R Irvin Journal: Am J Nephrol Date: 2022-01-31 Impact factor: 4.605
Authors: Ruifang Li-Gao; David A Hughes; Saskia le Cessie; Renée de Mutsert; Martin den Heijer; Frits R Rosendaal; Ko Willems van Dijk; Nicholas J Timpson; Dennis O Mook-Kanamori Journal: PLoS One Date: 2019-06-20 Impact factor: 3.240